"It has never been easy to differentiate between common general knowledge and that which is known by some. It has become particularly difficult with the modern ability to circulate and retrieve information. Employees of some companies, with the use of libraries and patent departments, will become aware of information soon after it is published in a whole variety of documents; whereas others, without such advantages, may never do so until that information is accepted generally and put into practice. The notional skilled addressee is the ordinary man who may not have the advantages that some employees of large companies may have. The information in a patent specification is addressed to such a man and must contain sufficient details for him to understand and apply the invention. It will only lack an inventive step if it is obvious to such a man. It follows that evidence that a fact is known or even well-known to a witness does not establish that that fact forms part of the common general knowledge. Neither does it follow that it will form part of the common general knowledge if it is recorded in a document. As stated by the Court of Appeal in General Tire & Rubber Co. v. Firestone Tyre & Rubber Co. Ltd. [1972] R.P.C. 457, at page 482, line 33: "
"In my judgment it is not sufficient to prove common general knowledge that a particular disclosure is made in an article, or series of articles, in a scientific journal, no matter how wide the circulation of that journal may be, in the absence of any evidence that the disclosure is accepted generally by those who are engaged in the art to which the disclosure relates. A piece of particular knowledge as disclosed in a scientific paper does not become common general knowledge merely because it is widely read, and still less because it is widely circulated. Such a piece of knowledge only becomes general knowledge when it is generally known and accepted without question by the bulk of those who are engaged in the particular art; in other words, when it becomes part of their common stock of knowledge relating to the art."
"It is certainly difficult to appreciate how the use of something which has in fact never been used in a particular art can ever be held to be common general knowledge in the art."
"I can readily accept that, faced with a disclosure which forms part of the state of the art, it may be obvious for the skilled person to seek to acquire further information before he embarks on the problem to which the patent provides a solution. But that does not make all such information part of the common general knowledge. The distinction is a fine one but it may be important. If information is part of the common general knowledge then it forms part of the stock of knowledge which will inform and guide the skilled person's approach to the problem from the outset. It may, for example, affect the steps it will be obvious for him to take, including the nature and extent of any literature search."
“120. Before leaving the argument based on common general knowledge alone, I will mention the words of Floyd J (as he then was) in Ratiopharm v Napp[2008] EWHC3070 (Pat) at paragraphs 155-159 and in particular the passage at paragraph 158 which warns that such attacks need to be scrutinised with care since they can be favoured by parties because the starting point is not obviously encumbered by inconvenient details of the kind found in documentary disclosures. I respectfully agree with Floyd J. Since it seems to me that this case provides a good example of the problems identified in ratiopharm I will add a few words of my own. 121. Normally the person attacking validity will rely on a particular concrete document or well defined prior use as a starting point. The fact that such a concrete item of prior art may be part of the common general knowledge is not the point. That is different from an attack based on common general knowledge alone. 122. Many inventions involve a combination of known features. However a combination of features, all of which individually were common general knowledge, can give rise to a valid patent claim if that combination is new and non-obvious. Patent trials are inevitably ex post facto and a key problem is to identify and avoid hindsight. Combinations of features can pose a particularly acute hindsight problem. The thing about concrete items of prior art, whether they are prior published documents or prior used products or processes, is that whatever combination of features that concrete prior art consists of, is not one which was created with hindsight knowledge of the invention. 123. The problem with arguments over common general knowledge alone is that the combination of features relied on is always and necessarily one created with hindsight knowledge of the invention, and worse, is one which the person attacking validity has not been able to find as a pre-existing combination in the concrete prior art. If they had they would have relied on that concrete prior art. Either the combination has not been made in the concrete prior art at all or it only appears with additional inconvenient details. If an invention is not obvious over the concrete prior art which is relied on, the court is entitled to be sceptical that an argument that it is nevertheless obvious over common general knowledge alone is correct. 124. The problem is illustrated in this case. Sometimes an invention belongs to a field which is not well documented but in this case Accord did not lack possible starting points. It has pleaded two documents and could easily have pleaded others, such as the existing SmPCs for subcutaneous methotrexate. However the documents contain what might have been thought of as "inconvenient" details. Russo does not mention subcutaneous administration by name and is aimed at JCA rather than RA. Russo is also a small study and was published six years before the priority date. Jansen does mention subcutaneous and is for RA but it does not mention pain and contains the two statements referred to above which Medac relies on. That the "inconvenient" details in Russo have not led to a finding of non-obviousness is not the point. To invent as a starting point in the prior art an amalgam of the best bits of the two cited documents while leaving out the inconvenient aspects, which is in effect what the argument was, created a combination which did not hitherto exist.”
“…The argument in this case had not been properly pleaded. That is not the defendants' fault because the parties agreed to treat Mr Townend's first report as a statement of the case. However the case then shifted very close to trial, which demonstrated why it should have been pleaded properly in the first place. Furthermore the argument presented a combination of common general knowledge features which had been created with hindsight knowledge of the patent. It was presented in a way which lacked inconvenient details which were found when the same ideas appeared in the committee documents and it presented points of common general knowledge at a level of generality which itself was crafted with hindsight.”
“According to one aspect of the present invention, there is provided a prepayment energy supply system including a pre-payment utility meter, and a digital cellular transceiver provided at a location, the utility meter having an associated location identifier unique to the location and a memory for storing pre-payment credits, the utility meter being arranged to communicate with a remote communication unit via the transceiver, the remote communication unit having a database of the unique identifiers and transceiver numbers, wherein a payment for crediting to a meter includes the unique identifier, the remote communication unit being arranged to determine the transceiver number from the unique identifier, to communicate with the utility meter via the transceiver and to add appropriate pre-payment credits to the memory. Utility meters must be fixed at, or very close to, the location to be metered because they need to measure the supply of the utility as it enters the location. Taking advantage of the fact that an installed meter is virtually immoveable, that the meter has an embedded unique and secure identifier that identifier satisfies criterion 3 (the location of the transaction is known) and meets "card present" requirements. The user interface unit enables the user (the purchaser) to confirm their identity and to prove that the card is present by inputting a transaction authorisation (such as by entering the card in a card reader and providing an authorisation code), therefore satisfying criteria 1 and 2. The transaction authorisation can be securely communicated to the financial institutions for fulfilment and settlement as a legitimate "card present" transaction.”
“Figure 5 is a schematic diagram of the system of Figure 4 according to one aspect of the present invention. Where a utility meter 10 is configured as a pre-pay meter, the location is also provided with an identification card. The identification card carries the unique identification code embedded within the utility meter 10 and allows somebody to credit pre-payments to the meter 10 remotely. On visiting a bank, supermarket or other facility offering pre-payment facilities 210, someone possessing the card can present it along with a pre-payment in order for the meter to be credited. Data from the card is obtained at the pre-payment facilities 210 by reading the card using a card reader. From the data, the unique identification code is obtained and communicated, along with the amount of pre-payment received, to a central communication unit 220. The communication unit 220 includes a database 230 of the unique identification codes cross-referenced with the digital cellular network number for the transceiver for the meter having that code. The code received from the pre-payment facility is crossreferenced in the database 230 and the digital cellular number is obtained. The communication unit 220 communicates with the meter 10 via the digital cellular network 120 and instructs it to credit the amount pre-paid. A pre-payment transaction does not have to be done by the occupant of the location and could be performed by other parties, including Government Agencies. In addition, the system could be configured such that pre-payment could be made from the home via the user interface unit 30 in the same manner as a regular financial transaction is made. Since the utility meter is in affixed place it provides a unique identification key that cc passports" all other intelligent devices within the location. The utility meter can use its unique electronic identity and its "fixed place" location to log the activity of all related Piconet devices.”
“(i) The first overarching principle is that contained in article 69 of the European Patent Convention. (ii) Article 69 says that the extent of protection is determined by the claims. It goes on to say that the description and drawings shall be used to interpret the claims. In short the claims are to be construed in context. (iii) It follows that the claims are to be construed purposively—the inventor's purpose being ascertained from the description and drawings. (iv) It further follows that the claims must not be construed as if they stood alone—the drawings and description only being used to resolve any ambiguity. Purpose is vital to the construction of claims. (v) When ascertaining the inventor's purpose, it must be remembered that he may have several purposes depending on the level of generality of his invention. Typically, for instance, an inventor may have one, generally more than one, specific embodiment as well as a generalised concept. But there is no presumption that the patentee necessarily intended the widest possible meaning consistent with his purpose be given to the words that he used: purpose and meaning are different. (vi) Thus purpose is not the be-all and end-all. One is still at the end of the day concerned with the meaning of the language used. Hence the other extreme of the Protocol—a mere guideline—is also ruled out by article 69 itself. It is the terms of the claims which delineate the patentee's territory. (vii) It follows that if the patentee has included what is obviously a deliberate limitation in his claims, it must have a meaning. One cannot disregard obviously intentional elements. (viii) It also follows that where a patentee has used a word or phrase which, acontextually, might have a particular meaning (narrow or wide) it does not necessarily have that meaning in context. (ix) It further follows that there is no general ‘doctrine of equivalents’. (x) On the other hand purposive construction can lead to the conclusion that a technically trivial or minor difference between an element of a claim and the corresponding element of the alleged infringement none the less falls within the meaning of the element when read purposively. This is not because there is a doctrine of equivalents: it is because that is the fair way to read the claim in context. (xi) Finally purposive construction leads one to eschew the kind of meticulous verbal analysis which lawyers are too often tempted by their training to indulge.”
“45. Subject to a point which arises in connection with 495, the parties did not dispute that the correct approach to construction of a patent is that explained by Lord Hoffmann in his speech in Kirin Amgen v Hoechst Marion Roussel[2004] UKHL46;[2005] RPC 9 . The object is to ascertain what the person skilled in the art would understand the patentee to be using the words in the claim to mean. The Court of Appeal summarised the relevant principles in Virgin Atlantic Airways v Premium Aircraft Interiors UK[2009] EWCA Civ 1062 at [5]. There is no need to repeat them here. It is however worth emphasising one point. A number of BT's arguments on this appeal involve reading limitations into the claim which are not there as a matter of language, on the grounds that to do so would follow more closely that which is disclosed by way of example in the body of the specification. It must be remembered, however, that the specification and claims of the patent serve different purposes. The specification describes and illustrates the invention, the claims set out the limits of the monopoly which the patentee claims. As with the interpretation of any document, it is conceivable that a certain, limited, meaning may be implicit in the language of a claim, if that is the meaning that it would convey to a skilled person, even if that meaning is not spelled out expressly in the language. However it is not appropriate to read limitations into the claim solely on the ground that examples in the body of the specification have this or that feature. The reason is that the patentee may have deliberately chosen to claim more broadly than the specific examples, as he is fully entitled to do.”
“In the context of the prior art in this case, the following well defined question arises: is a customer account number such a location identifier, i.e. unique to the location and associated with the meter?”
“this aspect of the invention receives very little explanation in the Patent itself”
“programmed into the meter during factory configuration” did not satisfy the requirement of being “embedded”
“60. (1) Subject to the provisions of this section, a person infringes a patent for an invention if, but only if, while the patent is in force, he does any of the following things in the United Kingdom in relation to the invention without the consent of the proprietor of the patent, that is to say – (a) where the invention is a product, he makes, disposes of, offers to dispose of, uses or imports the product or keeps it whether for disposal or otherwise; (b) where the invention is a process, he uses the process or he offers it for use in the United Kingdom when he knows, or it is obvious to a reasonable person in the circumstances, that its use there without the consent of the proprietor would be an infringement of the patent; … (2) Subject to the following provisions of this section, a person (other than the proprietor of the patent) also infringes a patent for an invention if, while the patent is in force and without the consent of the proprietor, he supplies or offers to supply in the United Kingdom a person other than a licensee or other person entitled to work the invention with any of the means, relating to an essential element of the invention, for putting the invention into effect when he knows, or it is obvious to a reasonable person in the circumstances, that those means are suitable for putting, and are intended to put, the invention into effect in the United Kingdom.”
“(5) An act which, apart from this subsection, would constitute an infringement of a patent for an invention shall not do so if … (b) it is done for experimental purposes relating to the subject-matter of the invention;…”
“Trials carried out in order to discover something unknown or to test a hypothesis or even in order to find out whether something which is known to work in specific conditions, e.g. of soil or weather, will work in different conditions can fairly, in my judgment, be regarded as experiments. But trials carried out in order to demonstrate to a third party that a product works or, in order to amass information to satisfy a third party, whether a customer or a body such as the PSPS or ACAS, that the product works as its maker claims are not, in my judgment, to be regarded as acts done “for experimental purposes”
“73…The Federal Supreme Court of Germany considered the equivalent provision in Klinische Versuche (Clinical Trials) I[1997] RPC 623 . The only part of the court's official headnote that is relevant for present purposes is as follows (English translation): An act for experimental purposes which is related to the subject-matter of the invention and therefore legitimate can exist if a patented pharmaceutically active substance is used in clinical trials with the aim of finding whether and, where appropriate, in what form the active substance is suitable for curing or alleviating certain other human diseases. 74. In that case the substance in question (an interferon) was known for use in the treatment of rheumatoid arthritis and the defendants were conducting clinical trials to see if that substance could be used for treating other diseases such as cancer, AIDS and hepatitis. The invention – the thing that was claimed in the patent – was the substance as such. I can see that those clinical trials were squarely within the purpose of the exception, for their immediate purpose was to generate scientific information by experimenting with the substance that was the subject of the patent claim. 75. However, there must surely be an outward limit to that principle. Suppose the defendants in the German case had been selling a pharmaceutical that was fairly new to the market and their defence had been that, by so doing, they were gaining valuable information that was not otherwise available – contraindications, for instance, which could be stated in the product literature. Would that be acts done for 'experimental' purposes? 76. A defendant could always say, and with some truth, that by putting his product on the market (general or special) he was gaining valuable information that might even prompt him to modify his device in future. I have referred to Henry Ford's Model T car. I dare say that vehicle went through various modifications in the light of experience on the roads of early twentieth century America, and that is usually the case with any engineering product. 77. I acknowledge that the mere fact that the purpose of the defendant is commercial is no rebuttal of the statutory defence. After all, most pharmaceutical research organisations are commercial. They do research because they hope to make money one day. However, in the present case it cannot be denied that an immediate and present purpose of CoreValve is to generate revenue – which was not so in the German case. 78. I therefore think that a more complete statement of the principle – it did not arise in the German case – should involve the consideration whether the immediate purpose of the transaction in question is to generate revenue. 79. The relevant statutory phrase is "acts done for experimental purposes". The difficulty arises where the defendant has mixed purposes. I would reject the extreme proposition that, so long as one of the defendant's purposes is to generate information of scientific or technical value, it is irrelevant that another of his purposes is to generate ready cash. There may be no help for it but to consider the defendant's preponderant purposes. 80. On the evidence in this case I would hold that CoreValve's purposes are threefold: (1) to establish confidence in their product within the relevant market; (2) to generate immediate revenue of a substantial character; and (3) to gain information about clinical indications and, possibly, future modifications to be made to the physical structure of the device in the light of experience. I do not find that purpose (3) was their preponderant purpose. 81. I have not found this point easy, but on the whole I would hold that, on the assumption that the CoreValve device falls within Claim 1 of the patent in suit,section 60(5)(b) of the Patents Act 1977 is not a valid defence on the facts of this case.”
“I use the words “common design” because they are readily to hand, but there are other expressions in the cases, such as “concerted action” or “agreed on common action” which will serve just as well. The words are not to be construed as if they formed part of a statute. They all convey the same idea. This idea does not, as it seems to me, call for any finding that the secondary party has explicitly mapped out a plan with the primary offender. Their tacit agreement will be sufficient. Nor, as it seems to me, is there any need for a common design to infringe. It is enough if the parties combine to secure the doing of acts which in the event prove to be infringements.”
"(1) (a) Identify the notional 'person skilled in the art'; (b) Identify the relevant common general knowledge of that person; (2) Identify the inventive concept of the claim in question or if that cannot readily be done, construe it; (3) Identify what, if any, differences exist between the matter cited as forming part of the 'state of the art' and the inventive concept of the claim or the claim as construed; (4) Viewed without any knowledge of the alleged invention as claimed, do those differences constitute steps which would have been obvious to the person skilled in the art or do they require any degree of invention?"
"The question of obviousness must be considered on the facts of each case. The court must consider the weight to be attached to any particular factor in the light of all the relevant circumstances. These may include such matters as the motive to find a solution to the problem the patent addresses, the number and extent of the possible avenues of research, the effort involved in pursuing them and the expectation of success."
“What matters is whether or not the invention was technically obvious, not whether it was commercially obvious: see Hallen Co v Brabantia (UK) Ltd[1991] RPC 195 at 213 (Slade LJ). This does not necessarily mean that commercial considerations are irrelevant. The mindset of the skilled person may be conditioned by commercial considerations only to consider certain types of technical solution, as in Dyson Appliances Ltd v Hoover Ltd[2002] RPC 22 .”
"… whether there is any teaching in the prior art as a whole that would (not simply could, but would) have prompted the skilled person … to modify or adapt the closest prior art … thereby arriving at something falling within the terms of the claims, and thus achieving what the invention achieves". 16. At [46] Jacob LJ (with whom Lloyd and Stanley Burnton LJJ agreed) rejected the suggestion that this passage went as far as to suggest that it had to be shown that the skilled person would go ahead and implement the idea commercially. I would however not accept (and I do not think that the court in Actavis v Novartis was accepting) that it must be established in every case that the skilled person would necessarily have arrived at the precise combination claimed. That would be to place another straitjacket on the law of obviousness. The skilled person may be faced with a range of obvious possibilities, making it statistically unlikely that he will settle on any one of them. They will all be obvious: see for example the well known discussion in Brugger v MedicAid[1996] RPC 635 at 661 lines 6-21, per Laddie J. In Hallen Co. v Brabantia (UK) Ltd.[1991] RPC 195 this court rejected a suggestion that a "would" test was always to be preferred. At page 212, Slade LJ, giving the judgment of the court, said: "
“…Claim 1 is addressed in particular to the way in which a new credit is delivered to the meter. In the methods discussed above, this was achieved by insertion of coins, codes, cards or keys at the meter. Here it is being done through a digital cellular network. That much is trite. …. The conventional and obvious way for a Supplier to update that approach to take advantage of the new availability of low-cost wireless infrastructure was to use the Supplier’s own internal customer reference number – the account number – as the basis for retrieving the communication address for the customer’s meter, in the language of the claim, the transceiver number. The Patent takes a very different approach. It is, we submit, an approach that would be antithetical to the Supplier’s custom and practice, which would be to protect the system and keep control over all the information flows involved, and of all payments. That is tospecify that the transceiver number by retrieved by reference to a neutral referencenumber associated not with the customer but with the meter itself. That is theunique identifier of integer E.”
“It was not known that a meter could have an associated location identifier unique to the location as integer 1E requires. The account number was associated with the customer. I do not believe the MPAN was commonly known, but even if it was, it was not an identifier of the meter. 40,000 new MSNs were being rolled out each week, and suppliers did not have accurate MSN data, so these could not properly be called ‘identifiers’. …The idea of making a payment by reference to anything other than the account number was not known. In integer 1I, the payment includes the unique identifier. As I have explained above, the industry would not have used MSN as an identifier for the purposes of payments, as the data was too unreliable and changeable.”
“for the reasons I set out above….a payment must be identified as being intended for a particular device. As such, a unique identifier of that device must be used. It does not matter as far as the disclosure of Manson is concerned what identifier is used. The best known unique identifier of a meter as at the priority date was the meter serial number. It was also common general knowledge that in communicating solid state meters the meter serial number was normally stored in the meter.”
“To make a desired payment the customer would key in a security number, for example a number indicative of a particular credit card, this number would be displayed on the display 23 and may be checked before being transferred to a register in the unit 20. The customer would then key in the amount of the transfer and again check it on the indicator 23 before transferring to the register. The appropriate amount would be utilised immediately to update the credit/debit information in the register in the microprocessor 20 and would subsequently be transferred via the data link 26 to the central processor at the utility.”
"(1) Subject to the following provisions of this Act, the court or the comptroller may on the application of any person by order revoke a patent for an invention on (but only on) any of the following grounds, that is to say— … (d) the matter disclosed in the specification of the patent extends beyond that disclosed in the application for the patent, as filed, …"
"The task of the Court is threefold: (1) To ascertain through the eyes of the skilled addressee what is disclosed, both explicitly and implicitly in the application. (2) To do the same in respect of the patent as granted. (3) To compare the two disclosures and decide whether any subject matter relevant to the invention has been added whether by deletion or addition. The comparison is strict in the sense that subject matter will be added unless such matter is clearly and unambiguously disclosed in the application either explicitly or implicitly."
"… the purpose of the claims in a patent is the identification of the ambit of the protection and disclosures are normally a matter for the specification. The application before the amendment clearly and ambiguously disclosed slips and cones which acted as hanger units. The amendment did not alter that disclosure. By using the phrase "liner hanger unit" in the claim the patentee did not disclose any other construction of liner hanger: the term was used to widen the ambit of the monopoly."
"… claims, as a source of disclosure, have no greater force than the other admissible documents… Mr Whittle is, I think, correct when he says that the claim covers those matters because the patentee chose to limit its claim by reference to features other than the three in question. In practical terms I do not think there is anything very surprising about that result since the purpose of the claims is the identification of the ambit of protection. Disclosures are normally a matter for the specification. One looks, no doubt, at the whole of the issued patent specification in determining what it discloses, but even so, I find no disclosure in claim 1."